InvestorsHub Logo
Followers 9
Posts 540
Boards Moderated 0
Alias Born 01/26/2014

Re: 123tom post# 586

Saturday, 03/01/2014 11:36:26 AM

Saturday, March 01, 2014 11:36:26 AM

Post# of 3836
Sorry all. It wasn't my intention to take this hub off on a tangent. I felt that the modified citrus pectin product was, in fact, very related to the value of GR-MD02 in that it is advertised as a galectin-3 blocker. Also I believe a competitor of GALT is La Jolla Pharm. and from what I understand, their NASH trial results are out just before GALT's. Based on my understanding, that drug is supposed to be based on a modified citrus pectin--also a Galectin blocker. Though, some of the differences between the GALT and LJPC drug candidates are spelled out here (p.21):

http://galectintherapeutics.com/wp-content/uploads/2014/01/20140210-GALT-Corporate-Presentation-final.pdf

Certainly not trying to bash GALT or it's product, just a firm believer in being informed. Plus, I really like the science side of this stuff.

I will try to stick to questions and info. that are more directly pertinent to the investment.

Thanks again for all of your help so far. I'm glad I found this place.
Best to all of you.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News